Search results - 5 results
Environmental risk assessment of clinical trials involving modified vaccinia virus Ankara (MVA)-based vectors.
Publication Type: Peer reviewed scientific article Authors: Goossens, Martine; Katia Pauwels; Nicolas Willemarck; Didier Breyer Source: Curr Gene Ther, Volume 13, Issue 6, p.413-20 (2013) Keywords: ...
Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination.
Publication Type: Peer reviewed scientific article Authors: Verheust, Céline; Goossens, Martine; Katia Pauwels; Didier Breyer Source: Vaccine, Volume 30, Issue 16, p.2623-32 (2012) Keywords: Animals ...
Should novel organisms developed using oligonucleotide-mediated mutagenesis be excluded from the EU Regulation
Publication Type: Non-peer reviewed scientific publication Authors: Didier Breyer; Philippe Herman; Brandenburger,A.; Gheysen,G.; Remaut,E.; Soumillion,P.; J. Van Doorsselaere; Custers,R.; Katia ...
Bringing scientists to the people--the Co-Extra website.
Publication Type: Peer reviewed scientific article Authors: Didier Breyer; Pierre Daubresse; Myriam Sneyers Source: Biotechnol J, Volume 2, Issue 9, p.1081-5 (2007) Keywords: Biotechnology ...
Genetic modification through oligonucleotide-mediated mutagenesis. A GMO regulatory challenge?
Publication Type: Peer reviewed scientific article Authors: Didier Breyer; Philippe Herman; Brandenburger, Annick; Gheysen, Godelieve; Remaut, Erik; Soumillion, Patrice; Van Doorsselaere, Jan; ...